Trial Profile
A prospective controlled phase II study of preoperative exisulind therapy initiated prior to radical prostatectomy: effect on apoptosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Exisulind (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 02 Feb 2010 Actual end date (Oct 2007) added reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2005 New trial record.